Literature DB >> 6785366

Bacterial interference between Clostridium difficile and normal fecal flora.

R D Rolfe, S Helebian, S M Finegold.   

Abstract

Clostridium difficile has been shown to be the cause of virtually all cases of pseudomembranous colitis related to the administration of antimicrobial agents. It is possible that some antimicrobial agents alter the normal bacterial flora of the gastrointestinal tract so as to permit colonization and/or proliferation by C. difficile. The inhibitory activity of representative fecal bacteria from 23 anaerobic and aerobic genera against C. difficile was examined using two in vitro procedures. Strains of bacteria in six of the genera inhibited the multiplication of C. difficile, with Lactobacillus organisms and group D enterococci displaying the most antagonistic activity. C. difficile was examined for its ability to inhibit the multiplication of several fecal strains of anaerobic and aerobic bacteria. All eight strains of C. difficile tested inhibited the growth of particular strains of bacteria in the genera Bacteroides, Peptococcus, and Peptostreptococcus.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6785366     DOI: 10.1093/infdis/143.3.470

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  40 in total

1.  Clostridium difficile colitis in children with cystic fibrosis.

Authors:  Sunny Zaheed Hussain; Cathy Chu; David P Greenberg; David Orenstein; Seema Khan
Journal:  Dig Dis Sci       Date:  2004-01       Impact factor: 3.199

Review 2.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

3.  Mapping interactions between germinants and Clostridium difficile spores.

Authors:  Amber Howerton; Norma Ramirez; Ernesto Abel-Santos
Journal:  J Bacteriol       Date:  2010-10-22       Impact factor: 3.490

Review 4.  Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis.

Authors:  R Postigo; J H Kim
Journal:  Infection       Date:  2012-07-31       Impact factor: 3.553

5.  Intestinal dysbiosis and depletion of butyrogenic bacteria in Clostridium difficile infection and nosocomial diarrhea.

Authors:  Vijay C Antharam; Eric C Li; Arif Ishmael; Anuj Sharma; Volker Mai; Kenneth H Rand; Gary P Wang
Journal:  J Clin Microbiol       Date:  2013-06-26       Impact factor: 5.948

6.  Clostridium difficile colitis secondary to intravenous vancomycin.

Authors:  J R Hecht; E J Olinger
Journal:  Dig Dis Sci       Date:  1989-01       Impact factor: 3.199

7.  The intestinal microbiota dysbiosis and Clostridium difficile infection: is there a relationship with inflammatory bowel disease?

Authors:  Justyna Bien; Vindhya Palagani; Przemyslaw Bozko
Journal:  Therap Adv Gastroenterol       Date:  2013-01       Impact factor: 4.409

8.  Clostridium difficile colitis.

Authors:  Judith L Trudel
Journal:  Clin Colon Rectal Surg       Date:  2007-02

Review 9.  The clinical significance of antibiotic-associated pseudomembranous colitis in the 1990s.

Authors:  M Andréjak; J L Schmit; A Tondriaux
Journal:  Drug Saf       Date:  1991 Sep-Oct       Impact factor: 5.606

10.  Clostridium difficile and cytotoxin in routine faecal specimens.

Authors:  J Q Nash; B Chattopadhyay; J Honeycombe; S Tabaqchali
Journal:  J Clin Pathol       Date:  1982-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.